Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 2007

View Archived Issues

Promising preclinical activity of a novel HIV clade C vaccine

Novel therapeutic options for inflammatory disorders disclosed in recent patents

Altana discloses novel compounds for treating respiratory disorders

Immunosuppression: induction therapy with alemtuzumab

Phase I results encourage further clinical development of mapatumumab

Pregabalin reduces fibromyalgia pain

Recent advances in corneal transplantation therapy presented at the ARVO meeting

Vertex presents highlights of first quarter

In vitro activity of CLS-1506 against ocular bacterial, fungi and viral pathogens

GVAX immunotherapy for leukemia studied in three new trials

Study identifies effective dose of epinastine nasal spray for seasonal allergic rhinitis

Dainippon Sumitomo reports novel antidiabetic agents in recent patent

RG-1068 shows utility in MRI imaging of the pancreas

Conatus financing to support phase II trials of CTS-1027

ALTU-135 begins phase III trials in cystic fibrosis patients with pancreatic insufficiency

NovaThera and Gamida Cell collaborate in lung repair and regeneration

FDA requests Silenor carcinogenicity study results as part of NDA filing

KineMed gains option to SR-B1 as target in atherosclerotic heart disease

Dosing completes in two phase IIa obesity trials of oleoyl-estrone

Azedra studied in phase I/II trial for malignant pheochromocytoma

Preclinical proof-of-concept achieved for SC-75741 in influenza A

ImmunoCellular Therapeutics' brain tumor vaccine begins phase I trial

ProCertus BioPharm closes Series A financing

New financing completed at Morria Biopharmaceuticals

Enrollment completed in final phase II trial for Testosterone MD-Lotion

Axcan and NicOx end development of NCX-1000

Approvable letter issued by FDA for Merck & Co.'s CINV therapy

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...